INTRATESTICULAR REGULATION OF LEYDIG CELL FUNCTION
Project Number5K04HD001031-02
Contact PI/Project LeaderPAPADOPOULOS, VASSILIOS
Awardee OrganizationGEORGETOWN UNIVERSITY
Description
Abstract Text
A prerequisite for normal spermatogenesis is the coordination of Leydig
cell function with the needs of the spermatogenic phase of the
seminiferous epithelium. This is achieved through the actio of
gonadotropins, and a reciprocal transfer of information between Leydig
cells and Sertoli cells. It is also now clear that a local modulation
of Leydig and Sertoli cells, possibly independent of LH and FSH, occurs
within the testis and that these paracrine interactions are important in
regulating sperm production under normal conditions, or as part of a
local compensatory mechanism which operates when Leydig cell function
needs to be supported. The proposed studies focus on the regulation of
Leydig cell function by Sertoli cells. Our first specific aim is the
purification and characterization of the Sertoli cell secreted protein
which stimulus Leydig cell steroidogenesis. Generation of antibodies,
partial amino acid sequencing, and molecular cloning of the bioactive
protein will permit us to determine its structure/function relationship[
as well as its relationship to other known protein(s). Identification
of the receptor system through which this Sertoli cell protein acts on
Leydig cells, and of the step(s) in the steroid biosynthetic pathway
which are regulated by this protein is our second specific aim. Part of
these studies will be to determine whether and how this protein modulates
Leydig cell responsiveness to LH. In view of our recent findings that the
polypeptide diazepam binding inhibitor (DB or endozephine) is a
paracrine/autocrine regulator of Leydig cell proliferation and
steroidogenesis, our third specific aim focuses on the understudying of
the mechanism of action of DB on Leydig cells.
Eunice Kennedy Shriver National Institute of Child Health and Human Development
CFDA Code
DUNS Number
049515844
UEI
TF2CMKY1HMX9
Project Start Date
01-December-1993
Project End Date
30-November-1998
Budget Start Date
01-December-1994
Budget End Date
30-November-1995
Project Funding Information for 1995
Total Funding
$67,500
Direct Costs
$62,500
Indirect Costs
$5,000
Year
Funding IC
FY Total Cost by IC
1995
Eunice Kennedy Shriver National Institute of Child Health and Human Development
$67,500
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5K04HD001031-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5K04HD001031-02
Patents
No Patents information available for 5K04HD001031-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5K04HD001031-02
Clinical Studies
No Clinical Studies information available for 5K04HD001031-02
News and More
Related News Releases
No news release information available for 5K04HD001031-02
History
No Historical information available for 5K04HD001031-02
Similar Projects
No Similar Projects information available for 5K04HD001031-02